Commitments and Contingencies (Details Narrative) - USD ($)					3 Months Ended
	Jan. 09, 2023	Jan. 06, 2023	Jan. 04, 2023	Dec. 30, 2022	Mar. 31, 2023	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Issuance of ordinary shares through public offering, shares				5,800
Underwriting discount	$ 112,500		$ 1,500,000
Deferred underwriting commission						$ 584,518
Number of stock exercisable, shares			115,500
Share issued price per share			$ 2.00
Option description				The option and the 58,000 Units, as well as the 58,000 ordinary shares, the warrants to purchase 58,000 ordinary shares that may be issued upon exercise of the option and the rights to purchase 5,800 ordinary shares upon the completion of an initial business combination, have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the commencement of sales in our Initial Public Offering pursuant to Rule 5110(e)(1) of FINRA’s Rules, during which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative or put or call transaction that would result in the economic disposition of the securities, except as permitted under FINRA Rule 5110(e)(2). The Company estimated a fair value of the unit purchase option issued to the underwriters to be disclosed as an Equity with difference between the fair values and purchased cost to additional paid-in capital in the condensed balance sheets on the day of the IPO which is grant date.
Number of units option exercised, shares				$ 58,000
Warrants to purchase common shares				58,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of ordinary shares through public offering, shares				58,000	6,000,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of ordinary shares through public offering, shares	900,000	900,000	900,000
Sale of price per share	$ 10.00	$ 10.00
Number of stock exercisable, shares	38,700	900,000
Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of price per share				$ 100
Share price			$ 0.35
Deferred underwriting commission			$ 2,415,000
Number of stock exercisable, shares				58,000
Share issued price per share				$ 11.50